150 Mg Erlotinib Tablets IP

Name: 150 Mg Erlotinib Tablets IP
Brand: NEETCO BIOPHARMA
Price: 1800 INR
Availability: InStock

Price 1800 INR/ Bottle

Get a Price/Quote

MOQ : 1 Bottle

150 Mg Erlotinib Tablets IP Specification

Salt Composition
Erlotinib Hydrochloride 150 mg

Dosage Form
Tablet

Indication
Non-small cell lung cancer, Pancreatic cancer, Locally advanced or metastatic cancers

Feature
Targeted therapy, inhibits epidermal growth factor receptor (EGFR)

Ingredients
Erlotinib Hydrochloride, Excipients

Application
Oral administration for the treatment of specific cancers

Physical Color/Texture
White to off-white, film coated tablet

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, protected from moisture and light

Shelf Life
24 to 36 months from the date of manufacture

About 150 Mg Erlotinib Tablets IP

Explore the potent capabilities of 150 Mg Erlotinib Tablets IP-an outstanding, in-demand solution for cancer therapy. Renowned as a hot deal for healthcare professionals, this top-drawer medication boasts a gilt-edged reputation for targeting non-small cell lung and pancreatic cancers. Erlonat 150 and Erleva 150, the invincible brands in this category, deliver oral targeted therapy via robust blister packaging of 30 tablets per box. Formulated for efficacy and safety under prescription, these tablets, compliant with Indian Pharmacopoeia standards, exemplify reliability and international acclaim across India and export markets.

Key Applications and Use of 150 Mg Erlotinib Tablets IP

150 Mg Erlotinib Tablets IP are specifically designed for oral administration in diagnosed cases of non-small cell lung cancer, pancreatic cancer, and certain locally advanced or metastatic malignancies. Their surface is coated for ease of consumption, and the round, film-coated tablets ensure user comfort. Usage is strictly by prescription, under medical supervision, as part of targeted therapy involving epidermal growth factor receptor (EGFR) inhibition. These applications establish Erlotinib as a crucial component in the treatment protocols for specific cancers.

Reliable Supply, Rapid Delivery, and Global Reach

With steady supply rates, 150 Mg Erlotinib Tablets IP are available for prompt dispatch within India and select international markets. Shipped goods are expertly packaged in blister strips and boxes to preserve quality throughout transit. Express shipping options guarantee fast delivery times, meeting urgent clinical demands. From leading distributors to reputable exporters, these anticancer tablets are trusted by healthcare professionals worldwide for their invincible reliability and market accessibility.

FAQ's of 150 Mg Erlotinib Tablets IP:

Q: How should 150 Mg Erlotinib Tablets IP be administered?

A: 150 Mg Erlotinib Tablets IP are to be taken orally, as directed by a healthcare provider. Dosage and administration must strictly follow the oncologist's instructions for optimal therapeutic effect and minimized side effects.

Q: What are the main benefits of using Erlotinib Tablets IP in cancer treatment?

A: Erlotinib Tablets offer targeted therapy by inhibiting epidermal growth factor receptor (EGFR), potentially slowing or stopping cancer cell growth, particularly in non-small cell lung and pancreatic cancers. Their use is tailored for advanced or metastatic cases, maximizing clinical benefits.

Q: When should I expect my order to be delivered in export markets?

A: Shipped goods usually reach export customers within stipulated timeframes depending on the location. Express shipping can significantly reduce delivery time, ensuring that rates and timelines are competitive and prompt.

Q: What is the shelf life and storage recommendation for these tablets?

A: 150 Mg Erlotinib Tablets IP should be stored below 30C, protected from moisture and light. Their shelf life ranges from 24 to 36 months from the date of manufacture, ensuring product efficacy during this period.

Q: Where are 150 Mg Erlotinib Tablets IP available for purchase?

A: These tablets are readily available across India and can also be sourced for export in various international markets through certified distributors, suppliers, and exporters.

Q: What common side effects should users be aware of?

A: Common side effects of Erlotinib Tablets IP include rash, diarrhea, anorexia, fatigue, and nausea. Medical supervision is essential to manage these effects and ensure treatment safety.

Tell us about your requirement